BioBridgeXAll companies

Zenas BioPharma, Inc.

Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: ZBIO

Zenas BioPharma, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2023. Its shares trade on Nasdaq under the ticker ZBIO. It has reported private securities offerings to the US SEC, most recently $200 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Zenas BioPharma at a glance

Typepharmaceutical company
HeadquartersWaltham, Massachusetts, United States
Earliest incorporation on record2023
Stock listingNasdaq: ZBIO
SEC industryPharmaceutical Preparations
SEC CIK1953926

What does Zenas BioPharma do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $200.1 million sold (2024).

Frequently asked questions about Zenas BioPharma

Where is Zenas BioPharma headquartered?

Zenas BioPharma, Inc. is headquartered in Waltham, Massachusetts, United States.

What does Zenas BioPharma do?

Zenas BioPharma, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Zenas BioPharma a public company?

Yes. Zenas BioPharma, Inc. trades on Nasdaq under the ticker ZBIO.

When was Zenas BioPharma founded?

The earliest incorporation on record for Zenas BioPharma, Inc. is in 2023, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences